Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Iovance Biotherapeutics Inc (IOVA)
Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,035,827
  • Shares Outstanding, K 255,918
  • Annual Sales, $ 0 K
  • Annual Income, $ -395,890 K
  • 60-Month Beta 0.39
  • Price/Sales 4,783.33
  • Price/Cash Flow N/A
  • Price/Book 3.47
Trade IOVA with:

Options Overview Details

View History
  • Implied Volatility 114.89% ( -8.90%)
  • Historical Volatility 129.64%
  • IV Percentile 84%
  • IV Rank 22.87%
  • IV High 293.08% on 01/25/24
  • IV Low 62.06% on 09/20/23
  • Put/Call Vol Ratio 0.12
  • Today's Volume 72,947
  • Volume Avg (30-Day) 25,004
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 291,632
  • Open Int (30-Day) 266,846

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.44
  • Number of Estimates 7
  • High Estimate -0.40
  • Low Estimate -0.47
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +31.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.34 +117.17%
on 01/29/24
16.93 -5.83%
on 02/22/24
+7.86 (+97.28%)
since 01/22/24
3-Month
5.41 +194.64%
on 11/28/23
16.93 -5.83%
on 02/22/24
+10.55 (+195.46%)
since 11/22/23
52-Week
3.21 +396.57%
on 10/19/23
16.93 -5.83%
on 02/22/24
+8.54 (+115.41%)
since 02/22/23

Most Recent Stories

More News
This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst

It has good news in hand and plenty of room to grow.

WFC : 53.37 (+1.35%)
GS : 390.47 (+0.57%)
IOVA : 15.94 (+1.08%)
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value

These two businesses have viable paths to making investors richer -- possibly soon.

DNA : 1.3200 (+2.33%)
IOVA : 15.94 (+1.08%)
Why Iovance Biotherapeutics Stock Is Skyrocketing Today

Iovance is no longer a clinical-stage biotech.

IOVA : 15.94 (+1.08%)
3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk

The potential pitfall could be dire, but the odds seem to be in the biotech's favor.

IOVA : 15.94 (+1.08%)
5 Stocks Under $10 With 'Strong Buy' Ratings

Investing in cheap stocks priced under $10 can help you derive outsized gains over time. Here are five under-$10 stocks that analysts say are still a strong buy in this market.

WULF : 2.14 (-1.83%)
IOVA : 15.94 (+1.08%)
PGY : 1.5000 (+8.70%)
RKLB : 4.44 (-4.31%)
Is Iovance Biotherapeutics Stock a Buy Now?

It will take a while for its risks to resolve.

IOVA : 15.94 (+1.08%)
Is Iovance Biotherapeutics a Buy Before This Key FDA Decision?

Iovance shares have dropped by double digits over the past three years.

IOVA : 15.94 (+1.08%)
A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist

These biotech innovators have what it takes to soar.

IOVA : 15.94 (+1.08%)
NTLA : 27.18 (+1.12%)
What's Next for Iovance Biotherapeutics Stock?

Focusing on its clinical trial setback could mean missing the bigger picture.

IOVA : 15.94 (+1.08%)
2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street

Find out why investment bank analysts are hyperbullish for these stocks.

COMP : 3.40 (-2.58%)
DNA : 1.3200 (+2.33%)
IOVA : 15.94 (+1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own...

See More

Key Turning Points

3rd Resistance Point 19.02
2nd Resistance Point 17.97
1st Resistance Point 16.96
Last Price 15.94
1st Support Level 14.89
2nd Support Level 13.84
3rd Support Level 12.83

See More

52-Week High 16.93
Last Price 15.94
Fibonacci 61.8% 11.69
Fibonacci 50% 10.07
Fibonacci 38.2% 8.45
52-Week Low 3.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar